ndc semaglutide OZEMPIC (Semaglutide) 1MG SOL PEN INJ 4MG - 1X3 ML SOP Weight-loss drugs to be offered

DALYs and mortality related to obesity are the consequence of multiple comorbidities such as cardiovascular (i.e., heart failure) and metabolic diseases (i.e

In this paper, the authors describe the energy state-dependent regulation of the PVNGLP-1R to DVC circuit, resulting in altered food intake and metabolic health, mediated by GLP-1 receptor signalling.

No macro ratio beats long-term adherence - Sacks NEJM 2009

Supports Hormonal Weight Management: Specifically addresses the unique weight loss hurdles created by shifting hormones, making it easier for women over 40 to see real, lasting results

Learn how we can help you develop products to support GI comfort, muscle health, hydration, and more for consumers engaging with GLP-1 medications.

In 2025, more than 30 million Americans turned to GLP-1 injections to regulate their blood sugar, digestion and hunger